Regulatory Affairs Professionals Society (RAPS) Honors 2009 RAPS Fellows

Thursday, September 17, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+

PHILADELPHIA, Sept. 14 The Regulatory Affairs Professionals Society (RAPS) today honored the 2009 class of RAPS Fellows. The 16 Fellows are highly accomplished professionals working in the healthcare product regulatory field. They were honored during the opening session of the 2009 RAPS Annual Conference & Exhibition in Philadelphia.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070314/DCW091LOGO )

The RAPS Fellows program recognizes senior regulatory professionals for their continued significant contributions and leadership in the advancement of the profession and the professional. Fellows receive a dignified status and special services from RAPS and will serve as important resources for strategic dialogue, mentoring, implementation of special initiatives and international development. This is the second year of the RAPS Fellows program.

The 2009 RAPS Fellows are:

Members of the working media who wish to cover all or part of the 2009 RAPS Annual Conference & Exhibition should send an email to RAPS Communications Manager Zachary Brousseau at [email protected] or may register on site by going to the press office in room 104A of the Pennsylvania Convention Center. Media must bring valid press credentials or a letter from an assigning editor on company letterhead.

Conference sponsors include: Anson Group, Boston Scientific, BSI Healthcare, Crimson/Transperfect, Elsevier Business Intelligence, GE Healthcare, Kendle, Prolifiq Software, Stericycle and Tarius.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org

-- Chas Burr, MS, MBA, graduate program director, Health Product Regulation, Regis College; and president and principal consultant, Chas Burr Q/R Services Inc. -- Joy Cavagnaro, Ph.D., DABT, RAC, president and founder, Access BIO -- Nancy Chew, MS, RAC, president, Regulatory Affairs, North America Inc. -- Michael Hamrell, Ph.D., RAC, president, MORIAH Consultants -- Marie D. Kuker, RPh, RAC, president, Kuker Regulatory Consulting LLC -- Philip T. Lavin, Ph.D., executive chairman, Averion International -- Kenneth F. Miles, Ph.D., RAC, principal consultant, Miles Technologies Group LLC -- Penny Northcutt, RAC, CQA, president and CEO, REGSolutions LLC -- Peggy Pence, Ph.D., RAC, president and executive officer, Symbion Research International Inc. -- Kathryn Rangus, MS, MBA, RAC, president, Drug & Device Regulatory Services Inc. -- Robert Schiff, MS, PhD, RAC, CQA, president and CEO, Schiff & Company Inc. -- David C. Steinberg, MBA, president, Steinberg & Associates Inc. -- Susan Stewart, RAC, vice president, regulatory affairs, TransMolecular Inc. -- O. Reed Tarwater, Ph.D., RAC, director, pharmaceutical consulting services, Anson Group -- Henrietta Ukwu, MD, FACP, vice president, global regulatory affairs, Wyeth Pharmaceuticals -- Pamela Williamson, MBA, RAC, senior vice president, global regulatory affairs and corporate quality, Genzyme Corporation

SOURCE Regulatory Affairs Professionals Society (RAPS)


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook